427
Views
47
CrossRef citations to date
0
Altmetric
Laser treatment

Low-dose 1064-nm Q-switched Nd:YAG laser for the treatment of melasma

, , , , , , & show all
Pages 224-228 | Received 01 Aug 2009, Accepted 24 Sep 2009, Published online: 30 May 2010

References

  • Gupta AK, Nouri K, Talyor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006;55:1048–1065.
  • Cho TH, Hong SB, Ryou JH, Lee MH. Quality of life in melasma. Korean J Dermatol.. 2007;45:232–236.
  • Lawrence N, Cox SE, Brody HJ. Treatment of melasma with Jessner's solution versus glycolic acid: A comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination. J Am Acad Dermatol. 1997;36:589–593.
  • Khemis A, Kaiafa A, Quelle-Roussel C, Duteil L, Ortonne JP. Evaluation of efficacy and safety of rucinol serum in patients with melasma: A randomized controlled trial. Br J Dermatol. 2007;156:997–1004.
  • Wang CC, Sue YM, Yang CH, Chen CK. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: A randomized, physician-blinded, split-face comparative trial. J Am Acad Dermatol. 2006;54:804–810.
  • Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg. 2004;30:1196–1200.
  • Macedo O, Alster TS. Laser treatment of darker skin tones: A practical approach. Dermatol Ther. 2000;13:114–126.
  • Pandya A, Berneburg M, Ortonne JP, Picardo M. Guidelines for clinical trials in melasma. Br J Dermatol. 2007;156:21–28.
  • Friedman PM, Skover GR, Payonk G, Kauvar ANB, Greonemus RG. 3D In-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg. 2002;28:199–204.
  • Kang HY, Hwang JS, Lee JY, Ahn JH, Kim JY, Lee ES, The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006;154:1094–1099.
  • Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–116.
  • Alster TS, Williams CM. Treatment of nevus Ota by the Q-switched alexandrite laser. Dermatol Surg. 1995;21:592–596.
  • Kim YC, Kang WH, Bang DS, Myung NH, Rhee CK. Histopathologic, immunohistochemical, and electron microscopic findings of pigmented skin lesions immediately after Q-switched alexandrite laser treatment. Korean J Dermatol. 2003;41:1014–1021.
  • Lee MW. Combination 532-nm and 1064-nm lasers for noninvasive skin rejuvenation and toning. Arch Dermatol. 2003;139:1265–1276.
  • Schmults CD, Phelps R, Goldberg DJ. Nonablative facial remodeling, erythema reduction and histologic evidence of new collagen formation using a 300-microsecond 1064-nm Nd:YAG laser. Arch Dermatol. 2004;140:1373–1376.
  • Hruza GJ. Rejuvenating the aging face. Arch Dermatol. 2004;140:1383–1386.
  • Dayan SH, Vartanian AJ, Menaker G, Mobley SR, Dayan AN. Nonablative laser resurfacing using the long-pulse (1064-nm) Nd:YAG Laser. Arch Facial Plast Surg. 2003;5:310–315.
  • Anderson RR, Parrish JA. Selective photothermolysis: Precise microsurgery by selective absorption of pulsed radiation. Science. 1983;29:524–527.
  • Trelles MA, Allones I, Luna R. Facial rejuvenation with a nonablative 1320 nm Nd:YAG laser: A preliminary clinical and histologic evaluation. Dermatol Surg. 2001;27:111–116.
  • Trelles MA. Short and long-term follow-up of nonablative 1320 nm Nd:YAG laser facial rejuvenation [letter]. Dermatol Surg. 2001;27:781–782.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.